Compare ACU & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACU | STXS |
|---|---|---|
| Founded | 1867 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.1M | 177.0M |
| IPO Year | 1994 | 2004 |
| Metric | ACU | STXS |
|---|---|---|
| Price | $44.44 | $1.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 17.7K | ★ 373.6K |
| Earning Date | 04-24-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | 1.63 | ★ 16.67 |
| EPS | ★ 2.49 | N/A |
| Revenue | ★ $196,541,816.00 | $29,346,617.00 |
| Revenue This Year | $5.72 | $34.08 |
| Revenue Next Year | $5.19 | $35.18 |
| P/E Ratio | $17.99 | ★ N/A |
| Revenue Growth | ★ 1.05 | N/A |
| 52 Week Low | $35.50 | $1.56 |
| 52 Week High | $47.31 | $3.59 |
| Indicator | ACU | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 46.17 |
| Support Level | $40.48 | $1.74 |
| Resistance Level | $46.89 | $1.95 |
| Average True Range (ATR) | 1.33 | 0.09 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 51.08 | 52.63 |
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.